Wells Fargo & Company Zivo Bioscience, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.18 - $2.52 $11 - $25	10 Added 0.09%	11,328 $14,000
Q2 2023 Aug 15, 2023	BUY	$2.22 - $3.41 $4 - $6	2 Added 0.02%	11,318 $27,000
Q1 2023 May 12, 2023	BUY	$2.33 - $3.64 $2 - $3	1 Added 0.01%	11,316 $34,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $19.98 $1,036 - $8,351	-418 Reduced 3.56%	11,315 $28,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $23.64 $1 - $47	-2 Reduced 0.02%	11,733 $33,000
Q2 2022 Aug 12, 2022	SELL	$2.61 - $4.03 $4,230 - $6,532	-1,621 Reduced 12.14%	11,735 $46,000
Q1 2022 May 16, 2022	BUY	$2.44 - $4.27 $12,202 - $21,354	5,001 Added 59.86%	13,356 $51,000
Q4 2021 Feb 14, 2022	BUY	$2.73 - $4.48 $4,436 - $7,280	1,625 Added 24.15%	8,355 $24,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $5.45 $117 - $228	42 Added 0.63%	6,730 $30,000
Q2 2021 Aug 16, 2021	BUY	$0.11 - $5.21 $735 - $34,844	6,688 New	6,688 $32,000

Ticker ZIVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,419,660
Market Cap $164M
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietar...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.